Biotechnology
Jennerex, Inc. , and its South Korean partner Green Cross Corp., announced today that Phase I clinical trial results from its first-in-class lead product JX-594 were published in the premier journal Lancet Oncology. The majority of these end- stage patie
03:03 May 21, 2008
One ofDenmark's leading cancer centers has placed an order for three new treatment machines and nine advanced RapidArc volumetric arc therapy systems from Varian Medical Systems , the world leader in radiotherapy. Aarhus University Hospital plans to have
03:03 May 21, 2008
Sunesis Pharmaceuticals, Inc. today announced the initiation of the REVEAL-1 Phase 2 clinical trial of voreloxin , the company's lead anti-cancer therapeutic. The REVEAL-1 trial is being conducted in previously untreated elderly patients with acute myelo
03:03 May 21, 2008
Coventina Healthcare Enterprises, Inc., a leader in therapeutic warming and non-pharmacologic pain management systems, announced today that it has changed its name to ReGear Life Sciences, Inc. ReGear is expanding its line of patented therapeutic warming
03:03 May 21, 2008
The retiring baby boomers have challenged businesses across industries to replace knowledge while developing new leaders. Pharma, biotech and health care companies especially are faced with tough workforce challenges around sourcing, performance manageme
02:53 May 21, 2008
Skyepharma PLC - AGM Statement
02:50 May 21, 2008
Researchers from Dendreon Corporation today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small molecule, which targets Trp-p8 , to treat benign prostatic hyperplasia .
02:33 May 21, 2008
Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the FBR Capital Markets 12th Annual Spring Investor Conference to be held May 28 - May 29, 2008 at The Grand Hyatt in New York City. Mr. Jim Fickenscher, Chief F
02:30 May 21, 2008
According to a recently published report by Cutting Edge Information , new state reporting laws are negatively impacting pharmaceutical companies' ability to recruit influential thought leaders. The report, entitled 'Thought Leader Compensation: Establis
02:24 May 21, 2008
Romark Laboratories, L.C., a privately-owned biopharmaceutical company, today announced the completion of enrollment into its Phase II clinical trial to evaluate the safety and efficacy of nitazoxanide in combination with standard of care therapy in U.S.
02:03 May 21, 2008
Anesiva, Inc. today announced that the U.S. Food and Drug Administration has accepted the company's electronic supplemental New Drug Application filing to expand the indication for Zingo to treat pain associated with peripheral IV insertions and blood dr
02:03 May 21, 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
23:33 May 20, 2008
Daiichi Sankyo Co., Ltd. announced today that it has entered into an agreement to acquire the privately held firm, U3 Pharma AG, a German biotechnology company focusing on research into antibodies for the treatment of cancer.
21:13 May 20, 2008
SkyePharma PLC announces Succession Plan
21:03 May 20, 2008
Today at the World Congress of Cardiology , the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology,St George's University ofLondon, highlighted the importance of
20:13 May 20, 2008
Today at the World Congress of Cardiology , the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology,St George's University ofLondon, highlighted the importance of
20:13 May 20, 2008
Sahajanand Medical Technologies Pvt. Ltd. , Surat,India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the prospective, randomized nine months results of PAINT trial .
14:43 May 20, 2008
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced the presentation of data from a Phase 2b randomized, double-blind, placebo-controlled study assessing the safety and efficacy of linaclotide in patients with chronic constipatio
13:33 May 20, 2008
Ardea Biosciences, Inc. today announced that data was presented on the Company's lead mitogen-activated ERK kinase inhibitor, RDEA119, demonstrating potent activity in mouse models of colitis. An oral presentation of the data was given at Digestive Disea
13:33 May 20, 2008
Indevus Pharmaceuticals, Inc. today announced that data on NEBIDO , an investigational, long-acting intramuscular injection for the treatment of hypogonadism, was presented in a late breaker presentation at the 2008 American Urological Association Annual
11:23 May 20, 2008
43731 - 43750 of 48574 Stories
<<
<
Next 20 Biotechnology
>
>>
Search News
Daily News
